Xtx Topco LTD Invitae Corp Transaction History

Xtx Topco LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.01 - $0.61 $449 - $27,393	44,908 Added 109.66%	85,861 $0
Q4 2023 Feb 13, 2024	SELL	$0.42 - $0.72 $26,777 - $45,903	-63,755 Reduced 60.89%	40,953 $25,000
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $21,315 - $54,353	35,525 Added 51.35%	104,708 $62,000
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $358,335 - $556,273	-341,272 Reduced 83.14%	69,183 $78,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $284,683 - $647,654	237,236 Added 136.96%	410,455 $554,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $27,248 - $57,525	15,935 Added 10.13%	173,219 $322,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $215,560 - $979,099	113,453 Added 258.84%	157,284 $387,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $52,312 - $221,285	24,560 Added 127.45%	43,831 $107,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $121,021 - $300,434	19,271 New	19,271 $154,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.